Table 4.
Univariate Cox regression analysis of factors associated with graft survival in patients transplanted for hepatocellular carcinoma
| Hazard ratio (95% CI) | P-value | |
|---|---|---|
| Age | 1.01 (1.01–1.02) | <0.001 |
| MELD score | 1.01 (1.01–1.02) | <0.001 |
| BMI | 1.01 (1.00–1.02) | 0.138 |
| Gender | 0.406 | |
| Female | 1.00 | |
| Male | 1.05 (0.93–1.19) | |
| Race | 0.002 | |
| White | 1.00 | |
| African-American | 1.19 (1.01–1.40) | 0.036 |
| Asian | 0.73 (0.60–0.89) | 0.002 |
| Hispanic | 0.97 (0.85–1.12) | 0.688 |
| Other | 0.49 (0.50–1.24) | 0.305 |
| Cirrhosis | 0.742 | |
| No | 1.00 | |
| Yes | 0.98 (0.88–1.10) | |
| Diabetes | 0.017 | |
| No | 1.00 | |
| Yes | 1.14 (1.02–1.27) | |
| Lamivudine therapy | 0.089 | |
| No | 1.00 | |
| Yes | 0.30 (0.07–1.20) | |
| Hepatitis B immunoglobulin | 0.219 | |
| No | 1.00 | |
| Yes | 0.67 (0.36–1.27) | |
| Viral status | <0.001 | |
| HBV−/HCV− | 1.00 | |
| HBV+/HCV− | 0.67 (0.52–0.85) | 0.001 |
| HBV−/HCV+ | 1.13 (1.01–1.27) | 0.030 |
| HBV+/HCV+ | 0.97 (0.67–1.42) | 0.894 |
95% CI, 95% confidence interval; MELD, Model for End-stage Liver Disease; BMI, body mass index; HBV, hepatitis B virus; HCV, hepatitis C virus.